Relative Strength Alert For ADMA Biologics

Group 1 - The core idea presented is that the Relative Strength Index (RSI) can be used to gauge market sentiment, indicating when a stock may be oversold or overbought [1] - ADMA Biologics Inc's shares have reached an RSI of 29.7, indicating they are in oversold territory, with a recent trading price of $15.14 per share [2] - The S&P 500 ETF (SPY) has a significantly higher RSI of 67.8, suggesting that ADMA's recent selling pressure may be nearing exhaustion, presenting potential buying opportunities [2][4] Group 2 - ADMA's 52-week trading range shows a low of $13.50 and a high of $25.67, with the last trade recorded at $15.30 [4]